Immunization with dendritic cells loaded with α-galactosylceramide at priming phase, but not at boosting phase, enhances cytotoxic T lymphocyte activity against infection by intracellular bacteria

FEMS Immunology and Medical Microbiology

Volumn 51, Issue 2, 2007, Pages 350-362

  Enomoto, Noriyuki ^a   Nagata, Toshi ^a   Suda, Takafumi ^a   Uchijima, Masato ^a   Nakamura, Yutaro ^a   Chida, Kingo ^a   Nakamura, Hirotoshi ^a   Koide, Yukio ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

galactosylceramide; Cytotoxic T lymphocyte; Dendritic cell; Listeria monocytogenes; Memory cell

Indexed keywords

ALPHA GALACTOSYLCERAMIDE; DENDRITIC CELL VACCINE; EPITOPE; GAMMA INTERFERON; GLYCYLTYROSYLLYSYLASPARTYLGLYCYLASPARAGINYLGLUTAMYLTYROSYLISOLEUCINE; L SELECTIN; LISTERIOLYSIN O; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BACTERIAL CELL; BACTERIAL INFECTION; BAGG ALBINO MOUSE; CD8+ T LYMPHOCYTE; CELLULAR IMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOTOXIC T LYMPHOCYTE; DENDRITIC CELL; IMMUNIZATION; IN VIVO STUDY; LISTERIA MONOCYTOGENES; LISTERIOSIS; MEMORY T LYMPHOCYTE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROVOCATION TEST; SPLEEN;

ANIMALS; ANTIGENS, CD8; BACTERIAL TOXINS; COLONY COUNT, MICROBIAL; CYTOTOXICITY TESTS, IMMUNOLOGIC; DENDRITIC CELLS; EPITOPES, T-LYMPHOCYTE; GALACTOSYLCERAMIDES; HEAT-SHOCK PROTEINS; HEMOLYSIN PROTEINS; IMMUNIZATION, SECONDARY; L-SELECTIN; LISTERIA INFECTIONS; LISTERIA MONOCYTOGENES; MICE; MICE, INBRED BALB C; SPLEEN; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES, CYTOTOXIC; VACCINATION;

EID: 35148850963     PISSN: 09288244     EISSN: 1574695X     Source Type: Journal    
DOI: 10.1111/j.1574-695X.2007.00316.x     Document Type: Article

References (48)

1. Ahuja SS, Reddick RL, Sato N, Montalbo E, Kostecki V, Zhao W, Dolan MJ, Melby PC Ahuja SK (1999) Dendritic cell (DC)-based anti-infective strategies: DCs engineered to secrete IL-12 are a potent vaccine in a murine model of an intracellular infection. J Immunol 163 : 3890 3897.
2. Aichele P, Brduscha-Riem K, Oehen S, Odermatt B, Zinkernagel RM, Hengartner H Pircher H (1997) Peptide antigen treatment of naive and virus-immune mice: antigen-specific tolerance versus immunopathology. Immunity 6 : 519 529.
3. + T-cell memory and prime-boost response after dendritic-cell vaccination. Nat Med 11 : 748 756.
4. Banchereau J Steinman RM (1998) Dendritic cells and the control of immunity. Nature 392 : 245 252.
5. Bezbradica JS, Stanic AK, Matsuki N, Bour-Jordan HJ, Bluestone A, Thomas JW, Untmaz D, Kaer LV Joyce S (2005) Distinct roles of dendritic cells and B cells in Va14Ja18 natural T cell activation in vivo. J Immunol 174 : 4696 4705.
6. Burdin N, Brossay L Kronenberg M (1999) Immunization with α-galactosylceramide polarizes CD1-reactive NK T cells towards Th2 cytokine synthesis. Eur J Immunol 29 : 2014 2025.
7. Celluzzi CM, Mayordomo JI, Storkus WJ, Lotze MT Falo LD Jr. (1996) Peptide-pulsed dendritic cells induce antigen-specific CTL-mediated protective tumor immunity. J Exp Med 183 : 283 287.
8. Crowe NY, Uldrich AP, Kyparissoudis K, Hammond KJL, Hayakawa Y, Sidobre S, Keating R, Kronenberg M, Smyth MJ Godfrey DI (2003) Glycolipid antigen drives rapid expansion and sustained cytokine production by NK T cells. J Immunol 171 : 4020 4027.
9. + natural killer T cells by Mycobacterium bovis bacillus Calmette-Guérin. Eur J Immunol 29 : 650 659.
10. Fujii S, Shimizu K, Kronenberg M Steinman RM (2002) Prolonged IFN-γ-producing NKT response induced with α-galactosylceramide- loaded DCs. Nat Immunol 3 : 867 874.
11. Fujii S, Liu K, Smith C, Bonito AJ Steinman RM (2004) The linkage of innate to adaptive immunity via maturing dendritic cells in vivo requires CD40 ligation in addition to antigen presentation and CD80/86 costimulation. J Exp Med 199 : 1607 1618.
12. Gelin BG Broome CV (1989) Listeriosis. JAMA 261 : 1313 1320.
13. Gonzalez-Aseguinolaza G, de Oliveira C, Tomaska M et al 2000) α-Galactosylceramide-activated Vα14 natural killer T cells mediate protection against murine malaria. Proc Natl Acad Sci USA 97 : 8461 8466.
14. Gumperz JE Brenner MB (2001) CD1-specific T cells in microbial immunity. Curr Opin Immunol 13 : 471 478.
15. Harada M, Seino K, Wakao H, Sakata S, Ishizuka Y, Ito T, Kojo S, Nakayama T Taniguchi M (2004) Down-regulation of the invariant Vα14 antigen receptor in NKT cells upon activation. Int Immunol 16 : 241 247.
16. + T cells specific for a single nonamer epitope of Listeria monocytogenes are protective in vivo. J Exp Med 175 : 1531 1538.
17. Hayakawa Y, Takeda K, Yagita H, Kakuta S, Iwakura Y, Kaer LV, Saiki I Okumura K (2001) Critical contribution of IFN-γ and NK cells, but not perforin-mediated cytotoxicity to anti-metastatic effect of α- galactosylceramide. Eur J Immunol 31 : 1720 1727.
18. + T cell-dependent elimination of dendritic cells in vivo limits the induction of antitumor immunity. J Immunol 164 : 3095 3101.
19. + T cell responses to soluble antigen in vivo through direct interaction with dendritic cells. J Immunol 171 : 5140 5147.
20. Inaba K, Inaba M, Romani N, Aya H, Deguchi M, Ikehara S, Muramatsu S Steinman RM (1992) Generation of large numbers of dendritic cells from mouse bone marrow cultures supplemented with granulocyte/macrophage colony-stimulating factor. J Exp Med 176 : 1693 1702.
21. + Vα14 NKT cells play a crucial role in an early stage of protective immunity against infection with Leishmania major. Int Immunol 12 : 1267 1274.
22. Ishikawa A, Motohashi S, Ishikawa E, Fuchida H, Higashino K, Otsuji M, Iizasa T, Nakayhama T, Taniguchi M Fujisawa T (2005) A phase I study of α-galactosylceramide (KRN7000)-pulsed dendritic cells in patients with advanced and recurrent non-small cell lung cancer. Clin Cancer Res 11 : 1910 1917.
23. Kakimi K, Guidotti LG, Koezuka Y Chisari FV (2000) Natural killer T cell activation inhibits hepatitis B virus replication in vivo. J Exp Med 192 : 921 930.
24. + T cells. Nat Med 6 : 1154 1159.
25. Kitamura H, Iwakabe K, Yahata T et al 1999) The natural killer (NKT) cell ligand α-galactosylceramide demonstrates its immunopotentiating effect by inducing interleukin (IL)-12 production by dendritic cells and IL-12 receptor expression on NKT cells. J Exp Med 189 : 1121 1127.
26. Kronenberg M (2005) Toward an understanding of NKT cell biology: progress and paradoxes. Annu Rev Immunol 23 : 877 900.
27. Kronenberg M Gapin L (2002) The unconventional lifestyle of NKT cells. Nat Rev Immunol 2 : 557 568.
28. Lefrançois L Masopust D (2002) T cell immunity in lymphoid and non-lymphoid tissues. Curr Opin Immunol 14 : 503 508.
29. Manickan E, Kanangat S, Rouse RJ, Yu Z Rouse BT (1997) Enhancement of immune response to naked DNA vaccine by immunization with transfected dendritic cells. J Leukoc Biol 61 : 125 132.
30. Mayordomo JI, Zorina T, Stokus WJ et al 1995) Bone marrow-derived dendritic cells pulsed with synthetic tumor peptides elicit protective and therapeutic antitumor immunity. Nat Med 1 : 1297 1302.
31. Nakamura Y, Suda T, Nagata T, Aoshi T, Uchijima M, Yoshida A, Chida K, Koide Y Nakamura H (2003) Induction of protective immunity to Listeria monocytogenes with dendritic cells retrovirally transduced with a cytotoxic T lymphocyte epitope minigene. Infect Immun 71 : 1748 1754.
32. Nishimura T, Kitamura H, Iwakabe K et al 2000) The interface between innate and acquired immunity: glycolipid antigen presentation by CD1d-expressing dendritic cells to NKT cells induces the differentiation of antigen-specific cytotoxic T lymphocytes. Int Immunol 12 : 987 994.
33. Pamer EG (2004) Immune responses to Listeria monocytogenes. Nat Rev Immunol 4 : 812 823.
34. Ranieri E, Herr W, Gambotto A, Olson W, Rowe D, Robbins PD, Salvucci Kierstead L, Watkins SC, Gesualdo L Storkus WJ (1999) Dendritic cells transduced with an adenovirus vector encoding Epstein-Barr virus latent membrane protein 2B: a new modality for vaccination. J Virol 73 : 10416 10425.
35. + NKT cells participate in the early response to enteric Listeria monocytogenes infection. J Immunol 175 : 1137 1144.
36. Roberts AD, Ely KH Woodland DL (2005) Differential contributions of central and effector memory T cells to recall responses. J Exp Med 202 : 123 133.
37. Ronchese F Hermans IF (2001) Killing of dendritic cells: a life cut short or a purposeful death? J Exp Med 194 : F23 F26.
38. Seder RA Hill AV (2000) Vaccines against intracellular infections requiring cellular immunity. Nature 406 : 793 798.
39. Shaw JH, Grund VR, Durling L Caldwell HD (2001) Expression of genes encoding Th1 cell-activating cytokines and lymphoid homing chemokines by Chlamydia-pulsed dendritic cells correlates with protective immunizing efficacy. Infect Immun 69 : 4667 4672.
40. Silk JD, Hermans IF, Gileadi U et al 2004) Utilizing the adjuvant properties of CD1d-dependent NK T cells in T cell-mediated immunotherapy. J Clin Invest 114 : 1800 1811.
41. + T cells and natural killer cells is essential for the antimetastatic effect of α-galactosylceramide. Blood 99 : 1259 1266.
42. Uchijima M, Yoshida A, Nagata T Koide Y (1998) Optimization of codon usage of plasmid DNA vaccine is required for the effective MHC class I-restricted T cell responses against an intracellular bacterium. J Immunol 161 : 5594 5599.
43. + central memory T cells in protection from simian AIDS. J Immunol 175 : 3502 3507.
44. Wherry EJ, Teichgräber V, Becker TC, Masopust D, Kaech SM, Antia R, von Andrian UH Ahmed R (2003) Lineage relationship and protective immunity of memory CD8 T cell subsets. Nat Immunol 4 : 225 234.
45. + T cells to increase their abundance during virus infection. J Exp Med 201 : 1053 1059.
46. Wilson MT, Johansson C, Olivares-Villagómez D, Singh AK, Stanic AK, Wang C-R, Joyce S, Wick MJ Kaer LV (2003) The response of natural killer T cells to glycolipid antigens is characterized by surface receptor down-modulation and expansion. Proc Natl Acad Sci USA 100 : 10913 10918.
47. Woodland DL Blackman MA (2005) Vaccine development: baring the 'dirty little secret'. Nat Med 11 : 715 716.
48. Zaph C, Uzonna J, Beverley SM Scott P (2004) Central memory T cells mediate long-term immunity to Leishmania major in the absence of persistent parasites. Nat Med 10 : 1104 1110.